Vanessa Yardley

Overview

Best Publications

• Current scenario of drug development for leishmaniasis.

  Simon L Croft;Karin Seifert;Vanessa Yardley

  547
  Citations

• Chemotherapy of Leishmaniasis

  Simon L Croft;Vanessa Yardley

  510
  Citations

• Antitrypanosomal and Antileishmanial Activities of Flavonoids and Their Analogues: In Vitro, In Vivo, Structure-Activity Relationship, and Quantitative Structure-Activity Relationship Studies

  Deniz Tasdemir;Marcel Kaiser;Reto Brun;Vanessa Yardley

  475
  Citations

• Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.

  Michael B. Martin;Joshua S. Grimley;Jared C. Lewis;Huel T. Heath

  421
  Citations

• 2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.

  L Salmon-Chemin;E Buisine;Yardley;S Kohler

  358
  Citations

• Formulation of amphotericin B as nanosuspension for oral administration.

  O Kayser;C Olbrich;V Yardley;A F Kiderlen

  285
  Citations

• The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei

  Simon L. Croft;Diane Snowdon;Vanessa Yardley

  263
  Citations

• Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.

  Sandra Gemma;Gagan Kukreja;Caterina Fattorusso;Marco Persico

  256
  Citations

• Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites.

  Alessandro Baliani;Gorka Jimenez Bueno;Mhairi L. Stewart;Vanessa Yardley

  230
  Citations

• A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis

  Vanessa Yardley;Simon L Croft

  214
  Citations

• Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.

  Cecil Chan;Hong Yin;Jacqui Garforth;James H. McKie

  195
  Citations

• Gene Expression Analysis of the Mechanism of Natural Sb(V) Resistance in Leishmania donovani Isolates from Nepal

  Saskia Decuypere;Saskia Decuypere;Suman Rijal;Vanessa Yardley;Simonne De Doncker

  181
  Citations

• Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.

  V Yardley;S L Croft

  178
  Citations

• In Vivo Activities of Farnesyl Pyrophosphate Synthase Inhibitors against Leishmania donovani and Toxoplasma gondii

  Vanessa Yardley;Anis A. Khan;Michael B. Martin;Teri R. Slifer

  174
  Citations

• Cytotoxicity of (2,2':6',2''-terpyridine)platinum(II) complexes to Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei.

  Gordon Lowe;Anne Sophie Droz;Tirayut Vilaivan;George W. Weaver

  169
  Citations

• THE SENSITIVITY OF CLINICAL ISOLATES OF LEISHMANIA FROM PERU AND NEPAL TO MILTEFOSINE

  Vanessa Yardley;Simon L. Croft;Simonne De Doncker;Jean-Claude Dujardin

  161
  Citations

• Structure-activity relationships for the antileishmanial and antitrypanosomal activities of 1'-substituted 9-anilinoacridines.

  Swarna A. Gamage;David P. Figgitt;Stanley J. Wojcik;Raymond K. Ralph

  157
  Citations

• In vitro antiprotozoal activity of extract and compounds from the stem bark of Combretum molle.

  K. Asres;F. Bucar;E. Knauder;V. Yardley

  152
  Citations

• Antiprotozoal and cytotoxicity evaluation of sulfonamide and urea analogues of quinacrine

  Kelly Chibale;Hayley Haupt;Howard Kendrick;Vanessa Yardley

  146
  Citations

• Activities of Hexadecylphosphocholine (Miltefosine), AmBisome, and Sodium Stibogluconate (Pentostam) against Leishmania donovani in Immunodeficient scid Mice

  Patricia Escobar;Vanessa Yardley;Simon L. Croft

  138
  Citations